FDA Adverse Event Malfunction Summary report: N

SYNCHROMED II

MDR report key: 3260004 · Received August 1, 2013

Report

Report Number
3004209178-2013-12640
Event Type
Malfunction
Date Received
August 1, 2013
Date of Event
July 9, 2013
Report Date
July 9, 2013
Manufacturer
MDT PUERTO RICO OPERATIONS CO
Product Code
LKK
PMA / PMN Number
P860004
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OK, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PRODUCT ID 8709SC, SERIAL# (B)(4), IMPLANTED: 2007 (B)(6); PRODUCT TYPE CATHETER. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED, THE PATIENT HAD CONCERNS REGARDING ¿RESTRICTIONS¿ FROM INSURANCE COMPANIES, THE GOVERNMENT ETC., REGARDING THE QUANTITY OF MEDICATION USED AT REFILLS, I.E., ONLY ALLOWING 20ML CAN BE FILLED AT ONE TIME (EVEN IF A 40ML PUMP). THE PATIENT WAS ABOUT TO DECIDE WHEN THE BATTERY NEEDED TO BE REPLACED IN THE NEXT FEW MONTHS TO NOT HAVE THE PUMP REPLACED BUT JUST HAVE IT REMOVED AS THE PAIN PUMP HAD ¿TOO MANY ISSUES¿ ASSOCIATED WITH IT AND THE PATIENT COULDN¿T TRUST THE PAIN PUMP WOULD BE FORCED TO BE DISCONTINUED DUE TO ALL THE ¿PROBLEMS¿, WHICH THE PATIENT FELT INCLUDED THE LACK OF HCP WHO WILL TREAT PAIN PUMP PATIENT¿S DUE TO LOSS OF REVENUE OR NOT BEING REIMBURSED FOR THE COST OF MEDICATION WHICH THE PATIENT HAD BEEN FIGHTING TO KEEP HIS PAIN PUMP. THE PUMP WAS USED TO DELIVER FENTANYL AND BUPIVACAINE

Description of Event or Problem · 1

IT WAS LATER REPORTED THAT THE PATIENT WAS STILL HAVING CONCERNS WITH HIS DEVICE OR THERAPY BUT WAS WORKING WITH HIS HCP OR MANUFACTURE REPRESENTATIVE. IT WAS ALSO NOTED THE PATIENT HAS NOT SOUGHT FURTHER HELP. THE PATIENT CONTINUED TO HAVE CONCERNS REGARDING REIMBURSEMENT AND REFILLS ETC.. THE PATIENT ALSO HAD AN APPOINTMENT 8/21/13 FOR A REFILL WITH THE TECH.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
360404 SYNCHROMED II PUMP, INFUSION, IMPLANTED, PROGRAMMABLE LKK MDT PUERTO RICO OPERATIONS CO 863740

Patients

Seq Age Sex Outcome Treatment
1 00060 YR